enfortumab vedotin
seagen,astellas
['vedo', 'mibc', ' vedo', 'nmibc', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nct05014139', 'ev-104', 'bladder']
ev-104: phase 1 study of intravesical enfortumab vedotin for the treatment of patients with non-muscle invasive #bladdercancer. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology